More on NABI
Data
Financials
News
|
Nabi Biopharmaceuticals (NQ:NABI)
Delayed: 1.80
--0 (-0%)
|
Trade Now! |
|
| Previous Close |
$1.80 |
|
52 Week High |
$2.03 |
|
| Open |
$15.41 |
|
52 Week Low |
$1.53 |
| Day High |
$1.80 |
|
P/E |
N/A |
| Day Low |
$1.80 |
|
EPS |
$-0.21 |
| Volume |
200 |
|
|
|
-
Nov 8, 2012 05:33 PM
Nabi Biopharmaceuticals (NABI) Reports Q3 Loss of $0.12
-
Nov 5, 2012 08:16 AM
Nabi Biopharmaceuticals (NABI) Declares $1.108 Special Dividend; 65.2% Yield
-
Oct 17, 2012 09:33 AM
Pre-Open Movers 10/17: (CYMI) (PPHM) (CREE) Higher; (FTNT) (APOL) (STJ) Lower (more...)
-
Oct 17, 2012 07:46 AM
Nabi Biopharmaceuticals (NABI) halted on news
-
Oct 17, 2012 07:46 AM
Nabi Biopharma (NABI) Says NicVAX Phase II Missed Primary Endpoint
-
Oct 16, 2012 04:39 PM
Nabi Biopharmaceuticals (NABI) Plans Dividend of $0.99 to $1.1
-
Sep 18, 2012 06:44 AM
Nabi (NABI) and Biota (BAT.AX) Amend Merger Agreement
-
Sep 7, 2012 09:30 AM
Pre-Open Movers 9/7: (SWHC) (ULTA) (QCOR) Higher; (ADNC) (P) (INTC) Lower (more...)
-
Sep 6, 2012 05:29 PM
After-Hours Movers 9/6: (SWHC) (ULTA) (COO) Higher; (ADNC) (MFRM) (BLOX) Lower (more...)
-
Sep 6, 2012 05:24 PM
Nabi (NABI) To Bring in Russell Plumb as President and CEO Post-Merger
View All Articles
-
Nov 8, 2012 05:33 PM
Nabi Biopharmaceuticals (NABI) Reports Q3 Loss of $0.12
-
Oct 17, 2012 07:46 AM
Nabi Biopharma (NABI) Says NicVAX Phase II Missed Primary Endpoint
-
Aug 9, 2012 04:18 PM
Nabi Biopharmaceuticals (NABI) Tops Q2 EPS by 5c
-
May 10, 2012 04:19 PM
Nabi Biopharmaceuticals (NABI) Reports Q1 Loss of $0.03/Share
-
Apr 23, 2012 07:09 AM
Nabi (NABI) Announces Reverse Merger With Biota Holdings, Current Holders Will Own 26% of New Co.
-
Mar 14, 2012 04:15 PM
Nabi Biopharmaceuticals (NABI) Reports Q4 Loss of $0.05
-
Nov 7, 2011 08:32 AM
Nabi Biopharma (NABI) Says Second NicVAX(R) Phase III Trial Failed to Meet Primary Endpoint; Reviewing Strategic Alternatives
-
Nov 2, 2011 05:15 PM
Nabi Biopharmaceuticals (NABI) Reports Q3 Loss of $0.07, Sales Fall Short
-
Aug 3, 2011 05:07 PM
Nabi Biopharmaceuticals (NABI) Tops Q2 EPS by 3c
View All Major News
-
Nov 8, 2012 05:33 PM
Nabi Biopharmaceuticals (NABI) Reports Q3 Loss of $0.12
-
Nov 5, 2012 08:16 AM
Nabi Biopharmaceuticals (NABI) Declares $1.108 Special Dividend; 65.2% Yield
-
Oct 17, 2012 09:33 AM
Pre-Open Movers 10/17: (CYMI) (PPHM) (CREE) Higher; (FTNT) (APOL) (STJ) Lower (more...)
-
Oct 17, 2012 07:46 AM
Nabi Biopharmaceuticals (NABI) halted on news
-
Oct 17, 2012 07:46 AM
Nabi Biopharma (NABI) Says NicVAX Phase II Missed Primary Endpoint
-
Oct 16, 2012 04:39 PM
Nabi Biopharmaceuticals (NABI) Plans Dividend of $0.99 to $1.1
-
Sep 18, 2012 06:44 AM
Nabi (NABI) and Biota (BAT.AX) Amend Merger Agreement
-
Sep 7, 2012 09:30 AM
Pre-Open Movers 9/7: (SWHC) (ULTA) (QCOR) Higher; (ADNC) (P) (INTC) Lower (more...)
-
Sep 6, 2012 05:29 PM
After-Hours Movers 9/6: (SWHC) (ULTA) (COO) Higher; (ADNC) (MFRM) (BLOX) Lower (more...)
-
Sep 6, 2012 05:24 PM
Nabi (NABI) To Bring in Russell Plumb as President and CEO Post-Merger
View All Reports